| Exhibit Number | | | Exhibit Description | | |
| | | | | |
| 2.1 | | | Agreement and Plan of Merger, dated November 11, 2024, by and between Cardinal Health, Inc., Cure Acquisitionco, LLC, The GI Alliance Holdings, LLC and, solely in his capacity as representative as set forth therein, James Weber, M.D. (incorporated by reference to Exhibit 2.1 to Cardinal Health, Inc.’s Current Report on Form 8-K filed on November 12, 2024) | | |
| 3.1 | | | Amended and Restated Articles of Incorporation of Cardinal Health, Inc., as amended (incorporated by reference to Exhibit 3.1 to Cardinal Health’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, File No. 1-11373) | | |
| 3.2 | | | Cardinal Health, Inc. Restated Code of Regulations (incorporated by reference to Exhibit 3.1 to Cardinal Health's Current Report on Form 8-K filed on May 11, 2023, File No. 1-11373) | | |
| 4.1 | | | Indenture, dated as of June 2, 2008, between Cardinal Health, Inc., as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to Cardinal Health, Inc.’s Current Report on Form 8-K filed on June 2, 2008) | | |
| 4.2 | | | Second Supplemental Indenture, dated as of November 22, 2024, between Cardinal Health, Inc., as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Cardinal Health, Inc.’s Current Report on Form 8-K filed on November 22, 2024) | | |
| 4.3 | | | Form of 4.700% Senior Notes due 2026 (incorporated by reference to Exhibit 4.3 to Cardinal Health, Inc.’s Current Report on Form 8-K filed on November 22, 2024) | | |
| 4.4 | | | Form of 5.000% Senior Notes due 2029 (incorporated by reference to Exhibit 4.4 to Cardinal Health, Inc.’s Current Report on Form 8-K filed on November 22, 2024) | | |
| 4.5 | | | Form of 5.350% Senior Notes due 2034 (incorporated by reference to Exhibit 4.5 to Cardinal Health, Inc.’s Current Report on Form 8-K filed on November 22, 2024) | | |
| 4.6 | | | Form of 5.750% Senior Notes due 2054 (incorporated by reference to Exhibit 4.6 to Cardinal Health, Inc.’s Current Report on Form 8-K filed on November 22, 2024) | | |
| 10.1 | | | Term Loan Credit Agreement, dated December 5, 2024 (incorporated by reference to Exhibit 10.1 to Cardinal Health’s Current Report on Form 8-K filed on December 9, 2024, File No. 1-11373) | | |
| 10.2 | | | Bridge Facility Commitment Letter, dated November 11, 2024, by and among the Company and Bank of America, N.A. (incorporated by reference to Exhibit 10.1 to Cardinal Health’s Current Report on Form 8-K filed on November 12, 2024, File No. 1-11373) | | |
| 10.3 | | | 364-Day Credit Agreement, dated October 8, 2024 (incorporated by reference to Exhibit 10.1 to Cardinal Health’s Current Report on Form 8-K filed on October 10, 2024, File No. 1-11373) | | |
| 10.4 | | | Fourth Amendment, to Issuing and Paying Agency Agreement, dated October 8, 2024 (incorporated by reference to Exhibit 10.2 to Cardinal Health’s Current Report on Form 8-K filed on October 10, 2024, File No. 1-11373)* | | |
| 31.1 | | | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | | |
| 31.2 | | | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | | |
| 32.1 | | | Certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | | |
| 99.1 | | | Statement Regarding Forward-Looking Information | | |
| | | | | |
| 101.SCH | | | Inline XBRL Taxonomy Extension Schema Document | | |
| 101.CAL | | | Inline XBRL Taxonomy Extension Calculation Linkbase Document | | |
| 101.DEF | | | Inline XBRL Taxonomy Definition Linkbase Document | | |
| 101.LAB | | | Inline XBRL Taxonomy Extension Label Linkbase Document | | |
| 101.PRE | | | Inline XBRL Taxonomy Extension Presentation Linkbase Document | | |
| 104 | | | Cover Page Interactive Data File - formatted in Inline XBRL (included as Exhibit 101) | | |
| *Certain provisions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K | | | | | |